Drawing for Serial No. 79272325

USPTO serial 79272325

Serial No. 79272325

Reviewed by CopyMark Law Group

Reg. 6144278Status 706Renewal
Filing date
Status date
Registration date
Sep 8, 2020
Examiner
MISCHLER, MEGAN
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with Serial No. 79272325?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tony Hom

81 70TH STREET(whiskey)BKLYN, NY 11209

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents other than for medical or veterinary purposes; biological reagents other than for medical or veterinary purposes; biochemical catalysts; DNA encoded chemical compound for use in biochemical research; DNA encoded chemical preparations for use in biochemical research; intermediate of DNA encoded chemical compound for use in biochemical research; headpiece of DNA encoded chemical compound for use in biochemical researchACTIVE—
005Medicines for human purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseases; chemical preparations for medical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseases; chemical preparations for pharmaceutical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseases; chemico-pharmaceutical preparations for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseasesACTIVE—
035[ Shop window dressing; outdoor advertising; ] bill-posting; [ distribution of samples; ] publicity servicesACTIVE—
042Technical project studies, namely, technical research in the field of pharmaceutical studies; chemical research services; chemical research; biological research; research and development services relating to DNA encoded library synthesis; research and development services relating to DNA encoded library selection; research and development services relating to DNA encoded library data analysisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 9, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Oct 9, 202671AGREGISTERED-SEC.71 ACCEPTED—
Oct 5, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 8, 2026ES71TEAS SECTION 71 RECEIVED—
Sep 8, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 8, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 10, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 23, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 30, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 30, 2020FIMPFINAL DISPOSITION PROCESSED—
Dec 8, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 8, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 23, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 20, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 18, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 18, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2020RFNTREFUSAL PROCESSED BY IB—
Dec 17, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 17, 2019RFRRREFUSAL PROCESSED BY MPU—
Nov 29, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 27, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 26, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 25, 2019DOCKASSIGNED TO EXAMINER—
Nov 25, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 23, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 21, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance